Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Esophageal Molecular Biology, CLDN18.2

Geoffrey Ku

MD

🏢Memorial Sloan Kettering Cancer Center🌐USA

Associate Attending Physician, GI Oncology

32
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Geoffrey Ku at Memorial Sloan Kettering investigates the molecular underpinnings of esophageal and gastroesophageal junction cancers. His research has characterized genomic subtypes of esophageal adenocarcinoma and squamous cell carcinoma, identifying actionable alterations including CLDN18.2 and FGFR2 amplifications. He has contributed to multiple clinical trials evaluating molecularly selected therapies in esophageal cancer.

Share:

🧪Research Fields 研究领域

esophageal molecular biology
CLDN18.2 targeting esophageal
esophageal cancer molecular subsets
FGFR2 esophageal
biomarker esophageal trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Geoffrey Ku 的研究动态

Follow Geoffrey Ku's research updates

留下邮箱,当我们发布与 Geoffrey Ku(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment